Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, TDS, FVT

Global call for entries announced for 2024 Garmin Health Awards


Fourth annual awards program recognizes the world's most innovative solutions that successfully integrate Garmin wearable technology into health and wellness programs

OLATHE, Kan., May 7, 2024 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced a global call for entries for its 2024 Garmin Health Awards, celebrating the world's most innovative solutions that successfully leverage the power of Garmin technology into health and wellness programs. This year, Garmin will unveil a refreshed format for the Garmin Health Summit, plus a new, streamlined application process that means all applicants will now apply for only one award category: the Garmin Health Award. Also new this year, two different panels of judges will evaluate entries ? one made up of industry experts and the other of Summit attendees. Both the Expert's Choice Garmin Health Award and the People's Choice Garmin Health Award winners will be announced at the Garmin Health Summit on September 25 in Prague and will receive Garmin wearables worth up to $10,000.

"This year, Garmin Health is celebrating its 10th anniversary and we are thrilled to look back at how much we have grown over the years. One of our biggest accomplishments is the Garmin Health Awards, which have become one of the most coveted honors in the industry. Every year, we look forward to seeing the innovative solutions that leading providers submit and we are excited to continue advancing wellness initiatives all over the world through these prestigious awards." 
?Jörn Watzke, Senior Director Garmin Health

To be considered for the 2024 Garmin Health Awards, solutions or research projects should be established and active, and must use Garmin smartwatches, fitness trackers or smart scales. The submissions should also be aligned with Garmin Health's key areas of focus:

Applications will be accepted from May 7 through May 31, 2024. Each submission will be evaluated on customer benefit, scalability, uniqueness, innovation and performance. In June, finalists will be notified and invited to present their solution in person at the 2024 Garmin Health Summit. Expert judges and Summit attendees will evaluate the solutions and programs during the event, and all winners will be announced that evening. Click here for program details and application instructions.

VIDEO: Learn more about the Garmin Health Awards here and take a look at last year's Garmin Health Summit here

Garmin Health provides custom enterprise business solutions that leverage the Garmin extensive wearable portfolio and high-quality sensor data for applications in the corporate wellness, population health, and patient monitoring markets. The Garmin Health API allows third parties to ask customers to share their data in accordance with their specific privacy policies. As part of a global company that designs, manufactures and ships products worldwide, Garmin Health supports its customers' commerce and logistics needs, allowing enterprises to scale with a single, trusted partner. For more information, email our press team, connect with us on LinkedIn, or visit us online at garmin.com/health.

About Garmin International, Inc. Garmin International, Inc. is a subsidiary of Garmin Ltd. (NYSE: GRMN). Garmin Ltd. is incorporated in Switzerland, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. Garmin is a registered trademark. All other brands, product names, company names, trademarks and service marks are the properties of their respective owners. All rights reserved. 

Notice on Forward-Looking Statements:
This release includes forward-looking statements regarding Garmin Ltd. and its business. Such statements are based on management's current expectations.?The forward-looking events and circumstances discussed in this release may not occur and actual results could differ materially as a result of known and unknown risk factors and uncertainties affecting Garmin, including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 30, 2023, filed by Garmin with the Securities and Exchange Commission (Commission file number 0-31983).?A copy of such Form 10-K is available at https://www.garmin.com/en-US/investors/sec/. No forward-looking statement can be guaranteed.?Forward-looking statements speak only as of the date on which they are made and Garmin undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

Media Contact: 
Stephanie Schultz and Natalie Miller
913-397-8200
[email protected]

SOURCE Garmin International, Inc.


These press releases may also interest you

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...



News published on and distributed by: